Jason Goldstick, PhD

Research Associate Professor, Emergency Medicine

Research Associate Professor, Institute for Firearm Injury Prevention; Director, Statistics and Methods Section, Research Core, University of Michigan Injury Prevention Center

Injury Prevention Center Profile
Opioid Solutions Profile
Michigan Medicine Emergency Medicine Profile

Community Violence

Jason Goldstick headshot

Dr. Goldstick is the Director of Statistics and Methods in the CDC-funded University of Michigan Injury Prevention Center (UMIPC) and a Research Associate Professor of Emergency Medicine and at the Institute for Firearm Injury Prevention at the University of Michigan. Dr. Goldstick is a statistician by training and his past research spans several areas of social epidemiology including infectious disease, childhood problem behaviors, substance use, and violence. He has extensive expertise in statistical analyses, including predictive modeling and the analysis of longitudinal and spatially dependent data, especially as it applies to substance use, injury/violence data, and public health research. He has been the PI of a NIDA grant to study age-dependence in the predictors of substance use and its comorbidities, an NIAAA grant-funded to study predictors of alcohol use transitions and how those transitions coalesce with transitions in other health behaviors, and has received CDC contracts to use administrative claims data to study changes in opioid prescribing and related outcomes following the release of the CDC Guideline for Prescribing Opioids for Chronic Pain. His current and ongoing work focuses on violence and substance use epidemiology, overdose surveillance, and estimating behavioral intervention treatment effects. Specifically, Dr. Goldstick is currently PI of an R01 funded to use machine learning methods to optimally predict future violence involvement, and directs a statewide near real-time surveillance system for opioid overdoses in Michigan called the System for Opioid Overdose Surveillance, and is the lead statistician on over a half dozen current federally funded studies.